Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- Check5 days agoChange DetectedRemoved 'Prostate cancer' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.2%

- Check12 days agoChange DetectedAdded Prostate cancer to related topics and included MedlinePlus Genetics as a related topic.SummaryDifference0.2%

- Check19 days agoChange DetectedThe revision indicator on the page was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3; the investigator name and site (Mark Garzotto, MD, Portland VA Medical Center) and the prior revision reference (v3.4.2) were removed.SummaryDifference0.6%

- Check33 days agoChange DetectedAdded related topics Prostate cancer and MedlinePlus Genetics to the page. This enhances navigational context without altering the study details.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows 'Results Submitted' instead of 'No Results Posted,' indicating that trial results have been submitted.SummaryDifference0.1%

Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.